A Phase 3 effort evaluating ZADAXIN® (thymalfasin) as a possibleness ordinal factor for Hepatitis C tralatitious compounding therapy has meet been completed. Although the accumulation is currently existence analyzed and won’t be acquirable until after in the year, the lead…

Tags: Current